Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Masitinib 4.5 mg/kg/day
DRUG
2 trials
Sponsors
AB Science
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Mast Cell Activation Syndrome
Phase 2
Masitinib for the Treatment of Severe Mast Cell Activation Syndrome
NCT05449444
AB Science
Mast Cell Activation Syndrome
Start: 2022-07-01
End: 2024-12-31
Target: 72
Updated: 2023-02-06
Phase 3
Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients
Not yet recruiting
NCT07174492
AB Science
Amyotrophic Lateral Sclerosis (ALS)
Start: 2026-01-01
End: 2029-12-31
Target: 412
Updated: 2025-10-03